The manufacturing sector is undergoing rapid procedural changes and strategic shifts, driven by the increasing adoption of automation and artificial intelligence (AI). This transformation is being hailed as the next industrial revolution, and it is promising to reshape industries by enhancing prod.... |
Good MorningEquity markets started the week on a positive footing, with the S&P 500 hovering near break-even for the session. The move shows continued support at a critical level following the previous week's sell-off and indicates a high likelihood that new highs will be set soon. The question is how soon a new high will be set, and it could be before the New Year. The holiday season typically brings a year-end rally, and there are reasons to buy this year. Among them are fundamentally strong economic conditions and an outlook for accelerating earnings growth in 2025.
The first big hurdle for the market in 2025 will come in the second week of the new trading year. The monthly labor data, including the NFP report, are due and may not show the same robust conditions the market has come to expect. The latest jobless claims figures showed an alarming spike in total claims, which may indicate a negative shift in the employment market. Featured: 25 candidates screened. 5 made it. (Ad) 
| Industrials | |
The manufacturing sector is undergoing rapid procedural changes and strategic shifts, driven by the increasing adoption of automation and artificial intelligence (AI). This transformation is being hailed as the next industrial revolution, and it is promising to reshape industries by enhancing prod... Read the Full Story |
| From Our Partners | | One fund holds Nvidia, CrowdStrike, Palantir and other major AI names, and pays a 34% annualized distribution rate.
Instead of guessing which AI stock wins, this fund delivers income every single Thursday, up to $1,051 a month.
Chief Income Strategist Tim Plaehn breaks down what's inside the fund and how the weekly payouts work. | | Watch the free video to see how the weekly payouts work |
| Markets | |
The Dow Jones Industrial Average had the longest consecutive losing streak since 1978, falling for 10 straight days from December 5 to December 19, 2024. Meanwhile, the S&P 500 index, as tracked by the SPDR S&P 500 ETF Trust (NYSEARCA: SPY), was in a relatively flat trading range with six ... Read the Full Story |
| Finance | |
These three stocks, which are at or near the top of their respective industries, just increased dividends by double-digit percentages. Below, I’ll reveal how much these companies are paying out to shareholders now. I’ll also touch on notable share buyback news. Plus, I’ll provide... Read the Full Story |
| From Our Partners | | Tobacco, telecom, pipelines, and healthcare real estate trade at 10 to 15 times earnings while the index yields about 1 percent.
A free report highlights seven cash-generating stocks with a 5 percent forward yield floor and roughly 6.5 percent average cash yield, capped at two picks per sector.
Each pick includes coverage numbers and an honest bear case. Five of the seven have raised payouts for 17 to 56 straight years. | | Get the seven high-yield dividend stocks free now |
| Technology | |
Every earnings season has its share of overreactions, as stocks can overshoot on the upside and the downside. The fear of missing out (FOMO) can trigger panic and a leapfrog mentality where emotions drive extensive overreactions. Investors can develop FOMO when they believe a stock is going higher... Read the Full Story |
| Consumer Discretionary | |
Carnival Cruise Lines' (NYSE: CCL) share price is up about 50% for 2024 and rallying in the second half because the business is strong. Details from fiscal 2025 include sustained growth following industry normalization, record results, and improving guidance. Results include healthy cash flow, b... Read the Full Story |
| From Our Partners | | Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade.
This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan. | | Claim your free options guide and start building real trading knowledge |
| Communication Services | | On Dec. 12, shares of media giant Warner Bros. Discovery (NASDAQ: WBD) rallied over 15%. This immense gain was due to an announcement that the firm will restructure its business, which offers several key potential benefits. Wall Street analysts have raised their price targets on average, but as of t... Read the Full Story |
| Materials | |
The chemicals industry—companies creating chemicals used in industrial, commercial, and a variety of other applications—thrived for many years leading up to and including the COVID-19 pandemic. However, a recent report by McKinsey & Co. shows that the period since the end of the pa... Read the Full Story |
| Industrials | |
The transportation sector is currently experiencing a significant power shift, marked by rising freight rates and a tightening of capacity. This shift favors carriers over shippers, allowing companies such as J.B. Hunt Transport Services (NASDAQ: JBHT) and FedEx Corporation (NYSE: FDX) to capitali... Read the Full Story |
| Consumer Discretionary | | The stock market is not the same as it was 20 or 30 years ago when every asset class and product was isolated in its own price action and narrative. However, today’s market is very different, as everything is connected, from bonds to basic materials and commodities. In this way, stocks and exc... Read the Full Story |
| Industrials | |
FuelCell Energy’s (NASDAQ: FCEL) FQ4 2024 report had plenty of positive details, but the net result was not good. The company struggles to gain traction, losses continue to mount, and short interest grows, likely pushing the market lower. Short interest, which was running above 25% at the... Read the Full Story |
| Tuesday's Early Bird Stock Of The Day Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California. | Should I Buy Veeva Systems Stock? VEEV Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Veeva Systems was last updated on Thursday, October 15, 2026 at 7:32 PM.
Veeva Systems Bull Case -
Veeva Systems Inc. recently expanded its partnership with IQVIA, which selected Veeva's Clinical Trial Management System, electronic Trial Master File, Study Startup, and Site Connect products as enterprise standards across its global research operations. This strategic move deepens Veeva's role in clinical execution workflows and broadens its reach across contract research and biopharma customers, potentially increasing recurring revenue and customer retention.
-
The company reported strong third-quarter earnings, beating analysts' consensus estimates with $2.35 in earnings per share compared to the expected $2.23. Revenue also exceeded expectations at $927.96 million, up 17.6% year-over-year, demonstrating robust demand for its cloud-based software solutions in the life sciences industry.
-
Veeva Systems Inc. has set aggressive guidance for fiscal year 2027, projecting earnings per share of $9.21 and revenue of $3.7 billion. This guidance significantly exceeds the consensus estimates of $8.58 for EPS and $3.6 billion for revenue, indicating management's confidence in continued growth and operational efficiency.
-
The stock is currently trading at $313.01, near its 52-week high of $315.02, reflecting strong investor sentiment and technical momentum. This price level suggests that the market is valuing the company's growth trajectory and market position highly, with institutional investors showing increased interest in the stock.
-
Veeva's Veeva Basics suite is gaining traction with more than 175 emerging biotechnology companies, supporting the company's strategy of building early relationships that may develop into larger, long-term customers as these firms advance their drug pipelines. This broadening adoption among early-stage biotechs could unlock long-term revenue opportunities.
Veeva Systems Bear Case -
The company's price-to-earnings ratio stands at 48.04, which is relatively high compared to many other software companies. This valuation may leave little room for error if growth slows or if the company fails to meet its aggressive earnings guidance, potentially leading to a significant stock price correction.
-
Insider selling has been notable, with executives such as Daniel J. Rizzo and Thomas D. Schwenger selling significant portions of their holdings in recent months. For example, Rizzo sold 4,841 shares in October, and Schwenger sold 10,000 shares in August, which could signal a lack of confidence in the stock's near-term upside or simply reflect personal financial planning.
-
Some institutional investors have reduced their stakes in Veeva Systems Inc. For instance, Curated Wealth Partners LLC cut its stake by 45.6% during the third quarter, and Seilern Investment Management Ltd sold 138,217 shares. These moves could indicate that some large investors are taking profits or reassessing their positions in the stock.
-
The company's research and development spending is expected to decelerate, as noted by Oppenheimer, which could impact its ability to innovate and maintain its competitive edge in the rapidly evolving life sciences technology sector. This deceleration may be a concern for investors who prioritize ongoing innovation and product development.
-
Veeva Systems Inc. does not pay a dividend, with a dividend yield of 0.00%. This may be a drawback for income-focused investors who prefer stocks that provide regular cash flows, especially in a market where dividend-paying stocks are often favored for their stability and income potential.
| | View Today's Stock Pick |
|
| |
|
|
